MAJI (Exousia Pro) Days Payable: 0.00 (As of Jan. 2021)

What is Exousia Pro Days Payable?

Exousia Pro MAJI -12.24% Days Payable is 0.00 as of Jan. 2021.

Exousia Pro's average Accounts Payable for the three months ended in Jan. 2021 was $0.00 Mil. Exousia Pro's Cost of Goods Sold for the three months ended in Jan. 2021 was $0.00 Mil.

The historical rank and industry rank for Exousia Pro's Days Payable or its related term are showing as below:

MAJI's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Exousia Pro's Days Payable stayed the same from Jan. 2020 (0.00) to Jan. 2021 (0.00). stayed the same

Exousia Pro Days Payable Related Terms

Exousia Pro Days Payable Historical Data

* Premium members only.

The historical data trend for Exousia Pro's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exousia Pro Days Payable Chart

Exousia Pro Annual Data

Trend

Apr11

Apr12

Apr18

Apr19

Days Payable

0.00

Exousia Pro Quarterly Data
	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

MAJI vs HCCH, GRNV, AGBA: Days Payable Comparison

For the Biotechnology subindustry, Exousia Pro's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exousia Pro Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exousia Pro's Days Payable distribution charts can be found below:

* The bar in red indicates where Exousia Pro's Days Payable falls into.

Save Embed

Exousia Pro Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Exousia Pro's Days Payable for the fiscal year that ended in Apr. 2019 is calculated as

	Days Payable (A: Apr. 2019 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Apr. 2018 )	+	Accounts Payable (A: Apr. 2019 ))	/	count )	/	Cost of Goods Sold (A: Apr. 2019 )	*	Days in Period
=	( (0.083	+	0.129)	/	2 )	/	0	*	365
=	0.106					/	0	*	365
=	N/A

Exousia Pro's Days Payable for the quarter that ended in Jan. 2021 is calculated as:

	Days Payable (Q: Jan. 2021 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Oct. 2020 )	+	Accounts Payable (Q: Jan. 2021 ))	/	count )	/	Cost of Goods Sold (Q: Jan. 2021 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Exousia Pro (MAJI) has a Days Payable of 0.00 as of Jan. 2021. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Exousia Pro and its competitors.

Is Exousia Pro's Days Payable too high?

Exousia Pro's current Days Payable is 0.00.

How does Exousia Pro's Days Payable compare to HCCH and GRNV?

Exousia Pro's Days Payable of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Payable is 113.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.56, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Exousia Pro and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Exousia Pro's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Exousia Pro stock overvalued right now?

Exousia Pro (MAJI) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Exousia Pro (MAJI), the current Days Payable is 0.00 as of Jan. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exousia Pro Business Description

Industry Healthcare Biotechnology

Comparable Companies HCCH GRNV AGBA LACQ ORSN JFK LOAC TZAC KXIN CPMD CCXX CCX FPAC VTIQ SPAQ FEAC CCH CPAA LSE:EVRA GHIV

Address 7901 4th Street North, No. 23494, St. Petersburg, FL, USA, 33702

Website https://www.nextelmedical.com

Exousia Pro Inc is a exosome-based biotechnology, develops and manufactures mammalian and plant-based exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company is developing new ways to exploit the therapeutic potential of exosomes, initially focused in the field of oncology. The platform technology of the company also helps treating a broad spectrum of viral infections.